vs

Side-by-side financial comparison of Alset Inc. (AEI) and Insight Molecular Diagnostics Inc. (IMDX). Click either name above to swap in a different company.

Alset Inc. is the larger business by last-quarter revenue ($1.3M vs $1.1M, roughly 1.1× Insight Molecular Diagnostics Inc.). On growth, Insight Molecular Diagnostics Inc. posted the faster year-over-year revenue change (-23.4% vs -85.4%). Alset Inc. produced more free cash flow last quarter ($-6.1M vs $-7.0M). Over the past eight quarters, Insight Molecular Diagnostics Inc.'s revenue compounded faster (154.4% CAGR vs -53.7%).

Alset Global GmbH is an Austrian technology and engineering company based in Graz that specialises in hydrogen-based clean mobility products. Alset Global is known for developing a Hybrid Hydrogen internal combustion engine that can run on either pure petrol, pure hydrogen or a combination of both. This technology offers a sustainable and clean alternative to petrol-based internal combustion engines. The technology has been developed to create an alternative technology to meet new emission ta...

Quest Diagnostics Incorporated is an American clinical laboratory. A Fortune 500 company, Quest operates in the United States, Puerto Rico, Mexico, and Brazil. Quest also maintains collaborative agreements with various hospitals and clinics across the globe.

AEI vs IMDX — Head-to-Head

Bigger by revenue
AEI
AEI
1.1× larger
AEI
$1.3M
$1.1M
IMDX
Growing faster (revenue YoY)
IMDX
IMDX
+62.1% gap
IMDX
-23.4%
-85.4%
AEI
More free cash flow
AEI
AEI
$921.0K more FCF
AEI
$-6.1M
$-7.0M
IMDX
Faster 2-yr revenue CAGR
IMDX
IMDX
Annualised
IMDX
154.4%
-53.7%
AEI

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
AEI
AEI
IMDX
IMDX
Revenue
$1.3M
$1.1M
Net Profit
$-23.0M
Gross Margin
35.2%
42.5%
Operating Margin
-2057.5%
Net Margin
-2015.4%
Revenue YoY
-85.4%
-23.4%
Net Profit YoY
-1491.5%
31.5%
EPS (diluted)
$-0.75

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
AEI
AEI
IMDX
IMDX
Q4 25
$1.3M
$1.1M
Q3 25
$998.8K
$260.0K
Q2 25
$1.1M
$518.0K
Q1 25
$1.1M
$2.1M
Q4 24
$8.9M
$1.5M
Q3 24
$5.0M
$115.0K
Q2 24
$1.1M
$104.0K
Q1 24
$6.1M
$176.0K
Net Profit
AEI
AEI
IMDX
IMDX
Q4 25
$-23.0M
Q3 25
$1.5M
$-10.9M
Q2 25
$-8.2M
$-9.7M
Q1 25
$-8.3M
$-6.7M
Q4 24
$2.3M
$-33.5M
Q3 24
$1.7M
$-13.5M
Q2 24
$-1.2M
$-4.5M
Q1 24
$-6.8M
$-9.1M
Gross Margin
AEI
AEI
IMDX
IMDX
Q4 25
35.2%
42.5%
Q3 25
24.3%
53.5%
Q2 25
23.3%
67.6%
Q1 25
27.2%
62.0%
Q4 24
51.4%
40.0%
Q3 24
40.5%
43.5%
Q2 24
26.4%
48.1%
Q1 24
23.5%
25.6%
Operating Margin
AEI
AEI
IMDX
IMDX
Q4 25
-2057.5%
Q3 25
-258.2%
-4249.2%
Q2 25
-250.7%
-1900.0%
Q1 25
-368.1%
-318.0%
Q4 24
21.5%
-2262.9%
Q3 24
-19.4%
-11752.2%
Q2 24
-249.3%
-4453.8%
Q1 24
-37.2%
-5265.3%
Net Margin
AEI
AEI
IMDX
IMDX
Q4 25
-2015.4%
Q3 25
151.4%
-4174.6%
Q2 25
-748.1%
-1880.7%
Q1 25
-780.1%
-312.0%
Q4 24
26.0%
-2255.1%
Q3 24
34.6%
-11733.0%
Q2 24
-109.9%
-4355.8%
Q1 24
-111.2%
-5186.9%
EPS (diluted)
AEI
AEI
IMDX
IMDX
Q4 25
$-0.75
Q3 25
$0.05
$-0.34
Q2 25
$-0.71
$-0.30
Q1 25
$-0.78
$-0.26
Q4 24
$0.24
$-2.19
Q3 24
$0.19
$-0.98
Q2 24
$-0.13
$-0.36
Q1 24
$-0.73
$-1.13

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
AEI
AEI
IMDX
IMDX
Cash + ST InvestmentsLiquidity on hand
$25.2M
$11.6M
Total DebtLower is stronger
Stockholders' EquityBook value
$121.1M
$-31.5M
Total Assets
$136.6M
$25.8M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
AEI
AEI
IMDX
IMDX
Q4 25
$25.2M
$11.6M
Q3 25
$25.5M
$18.7M
Q2 25
$25.6M
$24.3M
Q1 25
$25.2M
$31.0M
Q4 24
$27.2M
$8.6M
Q3 24
$16.7M
$3.4M
Q2 24
$18.9M
$9.3M
Q1 24
$23.7M
$5.6M
Total Debt
AEI
AEI
IMDX
IMDX
Q4 25
Q3 25
Q2 25
Q1 25
$116.5K
Q4 24
$123.1K
Q3 24
$137.9K
Q2 24
$137.8K
Q1 24
$145.8K
Stockholders' Equity
AEI
AEI
IMDX
IMDX
Q4 25
$121.1M
$-31.5M
Q3 25
$155.7M
$-9.2M
Q2 25
$72.8M
$1.1M
Q1 25
$76.4M
$10.2M
Q4 24
$81.3M
$-12.3M
Q3 24
$84.2M
$9.7M
Q2 24
$79.4M
$22.7M
Q1 24
$81.7M
$11.6M
Total Assets
AEI
AEI
IMDX
IMDX
Q4 25
$136.6M
$25.8M
Q3 25
$169.1M
$43.9M
Q2 25
$86.0M
$50.5M
Q1 25
$90.5M
$60.4M
Q4 24
$96.8M
$35.1M
Q3 24
$98.8M
$70.2M
Q2 24
$93.5M
$74.7M
Q1 24
$96.7M
$71.0M
Debt / Equity
AEI
AEI
IMDX
IMDX
Q4 25
Q3 25
Q2 25
Q1 25
0.00×
Q4 24
0.00×
Q3 24
0.00×
Q2 24
0.00×
Q1 24
0.00×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
AEI
AEI
IMDX
IMDX
Operating Cash FlowLast quarter
$-5.9M
$-5.5M
Free Cash FlowOCF − Capex
$-6.1M
$-7.0M
FCF MarginFCF / Revenue
-467.7%
-616.7%
Capex IntensityCapex / Revenue
13.4%
129.9%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-11.8M
$-25.4M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
AEI
AEI
IMDX
IMDX
Q4 25
$-5.9M
$-5.5M
Q3 25
$883.4K
$-4.5M
Q2 25
$-2.6M
$-6.3M
Q1 25
$-3.8M
$-5.9M
Q4 24
$5.2M
$-5.4M
Q3 24
$-2.9M
$-5.5M
Q2 24
$-4.4M
$-6.0M
Q1 24
$-1.5M
$-3.8M
Free Cash Flow
AEI
AEI
IMDX
IMDX
Q4 25
$-6.1M
$-7.0M
Q3 25
$822.4K
$-5.6M
Q2 25
$-2.7M
$-6.6M
Q1 25
$-3.8M
$-6.2M
Q4 24
$5.1M
$-5.6M
Q3 24
$-2.9M
$-5.6M
Q2 24
$-4.4M
$-6.2M
Q1 24
$-1.5M
$-3.9M
FCF Margin
AEI
AEI
IMDX
IMDX
Q4 25
-467.7%
-616.7%
Q3 25
82.3%
-2135.4%
Q2 25
-245.9%
-1279.5%
Q1 25
-357.3%
-288.4%
Q4 24
56.5%
-374.5%
Q3 24
-58.2%
-4884.3%
Q2 24
-392.3%
-5931.7%
Q1 24
-24.8%
-2189.8%
Capex Intensity
AEI
AEI
IMDX
IMDX
Q4 25
13.4%
129.9%
Q3 25
6.1%
403.8%
Q2 25
7.6%
67.4%
Q1 25
5.7%
14.4%
Q4 24
1.1%
14.4%
Q3 24
0.6%
75.7%
Q2 24
3.0%
183.7%
Q1 24
0.0%
13.6%
Cash Conversion
AEI
AEI
IMDX
IMDX
Q4 25
Q3 25
0.58×
Q2 25
Q1 25
Q4 24
2.22×
Q3 24
-1.66×
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons